GSK shares up 2% after court decision on prior Zantac ruling
Delaware court agrees to reviewHepatitis B drug gets fast track approvalNucala approval in JapanBiopharma giant GSK (GSK) was one of the top gainers in the FTSE today, rising 2% to £16.47 after releasing positive drug updates and...
28 August 2024
